Shionogi & Co., Ltd.

4507・Prime Market・Pharmaceuticals

Official website

Shionogi & Co., Ltd.

4507・Prime Market・Pharmaceuticals

Official website

Shionogi & Co., Ltd.4507

Reference Indicators

Market Cap

25,750¥100M

P/E (Forecast)

—

P/B

1.5x

Dividend Yield (Forecast)

2.63%

ROE

12.2%

EV/EBITDA

13.0x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	335,138	426,684	410,073	438,268	499,677
Cost of Sales	55,415	62,246	57,602	63,826	82,450
Gross Profit	279,722	364,437	377,479	374,441	417,226
SG&A Expenses	91,771	97,775	99,651	101,873	126,905
Operating Income	110,312	149,003	153,310	156,603	166,725
Pre-tax Income	126,268	220,332	198,283	200,750	238,916
Income Taxes	12,829	35,836	37,708	31,215	33,002
Net Income	114,185	184,965	162,030	170,435	205,159
EBITDA	126,663	166,168	171,633	177,536	193,693
Gross Margin	83.5%	85.4%	92.1%	85.4%	83.5%
Operating Margin	32.9%	34.9%	37.4%	35.7%	33.4%
ROA	9.9%	14.1%	11.4%	11.1%	8.0%
ROE	11.7%	16.8%	13.1%	12.5%	12.2%